TMCI: שווי שוק לרווח נקי מותאם קצב צמיחה treace.com
The P/E ratio relative to medium-term growth underscores the reliability of Treace Medical Concepts (TMCI) orthopedic tool logistics, where resource diversification ensures supply stability. The integration of the Lapiplasty 3D system into physician training solidifies the brand's technological dominance in foot surgery. Steady demand for consumables ensures a predictable capital inflow. The value of 0.00 shows the current level of this parameter.
Treace Medical Concepts (TMCI) - פילוחי מדדים ודוחות פיננסיים
Investors use this ratio to identify undervalued assets by comparing the current P/E multiple with earnings growth rates. Tracking the PEG ratio allows for the mathematical confirmation of Treace Medical Concepts (TMCI) growth potential, given the company's expansion into the 3D foot correction segment and the significant volume of the untapped specialized orthopedic surgery market.
